Danaher vs Pfizer
Danaher (DHR), health care, and Pfizer (PFE), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Pfizer is worth $162.8B on the stock market and Danaher $159.5B: Pfizer is valued at 2% more. Danaher trades at 37.5 times earnings and Pfizer at 40.8. Over the past year Danaher's share price has moved +1.95% and Pfizer's +13.4%.
Key facts
- Danaher market value
- $159.5B
- Pfizer market value
- $162.8B
- Danaher P/E
- 37.5
- Pfizer P/E
- 40.8
- Danaher revenue
- $24.6BFY to 2025-12-31
- Pfizer revenue
- $62.6BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Danaher | Pfizer |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $159.5Blower | $162.8Bhigher |
| Revenue | $24.6Blower | $62.6Bhigher |
| Earnings | $3.6Blower | $7.8Bhigher |
| Employees | 58,000lower | 75,000higher |
| Total assets | $83.5Blower | $208.2Bhigher |
| Valuation | ||
| P/E | 37.5lower | 40.8higher |
| P/S | 6.5higher | 2.6lower |
| P/B | 3.0higher | 1.8lower |
| Dividend yield | 0.66%lower | 7.45%higher |
| Profitability | ||
| Operating margin | 19.1% | — |
| Balance sheet | ||
| Net assets | $52.5Blower | $86.5Bhigher |
| Total liabilities | $30.9Blower | $121.4Bhigher |
| Total debt | $18.4Blower | $64.8Bhigher |
| Cash on hand | $4.6Bhigher | $1.1Blower |
| Price change | ||
| Today | -1.41%lower | -1.02%higher |
| 1 year | +1.95%lower | +13.4%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Ken Fisher0.3% / 0.9%
Danaher only (18)
- Wallace Weitz7.0%
- Eric Bannasch4.8%
- Larry Robbins4.4%
- Doug Silverman2.3%
- Dan Loeb2.2%
- Daniel Sundheim2.1%
- Brandon Haley1.6%
- Steven Romick1.5%
- Dodge & Cox team1.2%
- Chase Coleman0.4%
- Israel Englander0.3%
- Primecap team0.3%
- Louis Bacon0.2%
- Stanley Druckenmiller0.2%
- Bill Gates0.2%
- Cliff Asness0.2%
- Rajiv Jain<0.1%
- Bill Nygren<0.1%
Pfizer only (10)
- Thomas Kahn1.9%
- Mark Boyar1.6%
- Prem Watsa1.5%
- Charles Brandes (founder)1.5%
- Josef Lakonishok1.0%
- Richard Pzena0.5%
- Bruce Berkowitz0.4%
- Jeremy Grantham (co-founder)0.1%
- Murray Stahl<0.1%
- Mairs & Power team<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Danaher / Pfizer). Who owns DHR · Who owns PFE
More on Danaher
Further comparisons
Danaher against its closest peers
Pfizer against its closest peers
Learn
Questions and answers
Which is bigger, Danaher or Pfizer?
By market value, Pfizer is the larger: $162.8B against $159.5B for Danaher. By revenue in its latest fiscal year, Pfizer is the larger: $62.6B against $24.6B for Danaher.
Which has the higher P/E ratio?
Pfizer: 40.8, against 37.5 for Danaher. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
Pfizer: 7.45%, against 0.66% for Danaher. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Pfizer: $64.8B, against $18.4B for Danaher. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Danaher and Pfizer?
In their latest 13F filings, Ken Fisher holds both.
Cite this page
Funkfolio, “Danaher vs Pfizer”, data as of 17 November 2026. https://funkfolio.com/compare/dhr-vs-pfe
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.